Pharmaceutical Manufacturing Market Research Report by Drug Development Type, Formulation, Therapy Area, Route of Administration Outlook, Prescription, Age Group, Distribution Channels, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Report
220 Pages
October 2022
Region: Global
360iResearch™
ID: 5454991

The Global Pharmaceutical Manufacturing Market size was estimated at USD 454.02 billion in 2021, USD 509.45 billion in 2022, and is projected to grow at a CAGR of 12.38% to reach USD 914.90 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Pharmaceutical Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drug Development Type, the market was studied across In-house and Outsource.
Based on Formulation, the market was studied across Capsules, Injectable, Powders, Sprays, Suspensions, and Tablets.
Based on Therapy Area, the market was studied across Cancer, Cardiovascular Diseases, Diabetes, Pain, and Respiratory Diseases.
Based on Route of Administration Outlook, the market was studied across Inhalations, Oral, Parenteral, and Topical.
Based on Prescription, the market was studied across Over-the-counter (OTC) Medicines and Prescription Medicines.
Based on Age Group, the market was studied across Adults, Children & Adolescents, and Geriatric.
Based on Distribution Channels, the market was studied across Non-retail and Retail.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pharmaceutical Manufacturing market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Manufacturing Market, including Actiza Pharmaceutical Pvt. Ltd., Aenova Group GmbH, AstraZeneca PLC, Bayer AG, Boehringer Ingelheim Group, Bristol-Myers Squibb, Catalent Inc., Eli Lilly And Company, F. Hoffmann-La Roche Ltd., Famar SA, GlaxoSmithKline PLC, Johnson & Johnson Private Limited, Lonza Group AG, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Piramal Pharma Solutions, Recipharm AB, Sanofi S.A., and Sun Pharmaceutical Industries Limited.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pharmaceutical Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Manufacturing Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Manufacturing Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Manufacturing Market?

Frequently Asked Questions about the Global Pharmaceutical Manufacturing Market

What is the estimated value of the Global Pharmaceutical Manufacturing Market?

The Global Pharmaceutical Manufacturing Market was estimated to be valued at $454.02 Billion in 2021.

What is the growth rate of the Global Pharmaceutical Manufacturing Market?

The growth rate of the Global Pharmaceutical Manufacturing Market is 12.3%, with an estimated value of $914.9 Billion by 2027.

What is the forecasted size of the Global Pharmaceutical Manufacturing Market?

The Global Pharmaceutical Manufacturing Market is estimated to be worth $914.9 Billion by 2027.

Who are the key companies in the Global Pharmaceutical Manufacturing Market?

Key companies in the Global Pharmaceutical Manufacturing Market include Actiza Pharmaceutical Pvt. Ltd., Aenova Group GmbH, AstraZeneca PLC, Bayer AG, Boehringer Ingelheim Group, Bristol, Myers Squibb, Catalent Inc. and F. Hoffmann.

Report Attribute	Details
No. of Pages	220
Published	October 2022
Forecast Period	2021 - 2027
Estimated Market Value ( USD ) in 2021	$ 454.02 Billion
Forecasted Market Value ( USD ) by 2027	$ 914.9 Billion
Compound Annual Growth Rate	12.3%
Regions Covered	Global
No. of Companies Mentioned	20

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in global demand for vaccines and drugs
5.1.1.2. Growing pharmaceutical R&D spending
5.1.1.3. Growth in geriatric population and incidence rate of chronic disorders
5.1.2. Restraints
5.1.2.1. Patent expiration of profitable drugs
5.1.3. Opportunities
5.1.3.1. Rise in focus towards healthcare needs of emerging nations
5.1.3.2. Rise in the investment and funding programs in pharmaceutical manufacturing sector
5.1.3.3. Emergence in the advancements of pharmaceutical manufacturing technologies
5.1.4. Challenges
5.1.4.1. Logistics complexities and limited skilled professionals
5.2. Cumulative Impact of COVID-19

6. Pharmaceutical Manufacturing Market, by Drug Development Type
6.1. Introduction
6.2. In-house
6.3. Outsource

7. Pharmaceutical Manufacturing Market, by Formulation
7.1. Introduction
7.2. Capsules
7.3. Injectable
7.4. Powders
7.5. Sprays
7.6. Suspensions
7.7. Tablets

8. Pharmaceutical Manufacturing Market, by Therapy Area
8.1. Introduction
8.2. Cancer
8.3. Cardiovascular Diseases
8.4. Diabetes
8.5. Pain
8.6. Respiratory Diseases

9. Pharmaceutical Manufacturing Market, by Route of Administration Outlook
9.1. Introduction
9.2. Inhalations
9.3. Oral
9.4. Parenteral
9.5. Topical

10. Pharmaceutical Manufacturing Market, by Prescription
10.1. Introduction
10.2. Over-the-counter (OTC) Medicines
10.3. Prescription Medicines

11. Pharmaceutical Manufacturing Market, by Age Group
11.1. Introduction
11.2. Adults
11.3. Children & Adolescents
11.4. Geriatric

12. Pharmaceutical Manufacturing Market, by Distribution Channels
12.1. Introduction
12.2. Non-retail
12.3. Retail

13. Americas Pharmaceutical Manufacturing Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States

14. Asia-Pacific Pharmaceutical Manufacturing Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam

15. Europe, Middle East & Africa Pharmaceutical Manufacturing Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Actiza Pharmaceutical Pvt. Ltd.
17.1.1. Business Overview
17.1.2. Key Executives
17.1.3. Product & Services
17.2. Aenova Group GmbH
17.2.1. Business Overview
17.2.2. Key Executives
17.2.3. Product & Services
17.3. AstraZeneca PLC
17.3.1. Business Overview
17.3.2. Key Executives
17.3.3. Product & Services
17.4. Bayer AG
17.4.1. Business Overview
17.4.2. Key Executives
17.4.3. Product & Services
17.5. Boehringer Ingelheim Group
17.5.1. Business Overview
17.5.2. Key Executives
17.5.3. Product & Services
17.6. Bristol-Myers Squibb
17.6.1. Business Overview
17.6.2. Key Executives
17.6.3. Product & Services
17.7. Catalent Inc.
17.7.1. Business Overview
17.7.2. Key Executives
17.7.3. Product & Services
17.8. Eli Lilly And Company
17.8.1. Business Overview
17.8.2. Key Executives
17.8.3. Product & Services
17.9. F. Hoffmann-La Roche Ltd.
17.9.1. Business Overview
17.9.2. Key Executives
17.9.3. Product & Services
17.10. Famar SA
17.10.1. Business Overview
17.10.2. Key Executives
17.10.3. Product & Services
17.11. GlaxoSmithKline PLC
17.11.1. Business Overview
17.11.2. Key Executives
17.11.3. Product & Services
17.12. Johnson & Johnson Private Limited
17.12.1. Business Overview
17.12.2. Key Executives
17.12.3. Product & Services
17.13. Lonza Group AG
17.13.1. Business Overview
17.13.2. Key Executives
17.13.3. Product & Services
17.14. Merck & Co., Inc.
17.14.1. Business Overview
17.14.2. Key Executives
17.14.3. Product & Services
17.15. Novartis AG
17.15.1. Business Overview
17.15.2. Key Executives
17.15.3. Product & Services
17.16. Pfizer, Inc.
17.16.1. Business Overview
17.16.2. Key Executives
17.16.3. Product & Services
17.17. Piramal Pharma Solutions
17.17.1. Business Overview
17.17.2. Key Executives
17.17.3. Product & Services
17.18. Recipharm AB
17.18.1. Business Overview
17.18.2. Key Executives
17.18.3. Product & Services
17.19. Sanofi S.A.
17.19.1. Business Overview
17.19.2. Key Executives
17.19.3. Product & Services
17.20. Sun Pharmaceutical Industries Limited
17.20.1. Business Overview
17.20.2. Key Executives
17.20.3. Product & Services

18. Appendix
18.1. Discussion Guide
18.2. License & PricingList of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET DYNAMICS
FIGURE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY DRUG DEVELOPMENT TYPE, 2027
FIGURE 14. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2021 VS 2027 (%)
FIGURE 17. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2021 VS 2027 (USD BILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY FORMULATION, 2027
FIGURE 19. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, 2018-2027 (USD BILLION)
FIGURE 21. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, 2018-2027 (USD BILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, 2018-2027 (USD BILLION)
FIGURE 23. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, 2018-2027 (USD BILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, 2018-2027 (USD BILLION)
FIGURE 25. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2021 VS 2027 (%)
FIGURE 26. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2021 VS 2027 (USD BILLION)
FIGURE 27. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY THERAPY AREA, 2027
FIGURE 28. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CANCER, 2018-2027 (USD BILLION)
FIGURE 29. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2027 (USD BILLION)
FIGURE 30. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, 2018-2027 (USD BILLION)
FIGURE 31. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN, 2018-2027 (USD BILLION)
FIGURE 32. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2027 (USD BILLION)
FIGURE 33. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2021 VS 2027 (%)
FIGURE 34. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2021 VS 2027 (USD BILLION)
FIGURE 35. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY ROUTE OF ADMINISTRATION OUTLOOK, 2027
FIGURE 36. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, 2018-2027 (USD BILLION)
FIGURE 37. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, 2018-2027 (USD BILLION)
FIGURE 38. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, 2018-2027 (USD BILLION)
FIGURE 39. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2027 (USD BILLION)
FIGURE 40. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2021 VS 2027 (%)
FIGURE 41. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2021 VS 2027 (USD BILLION)
FIGURE 42. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY PRESCRIPTION, 2027
FIGURE 43. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, 2018-2027 (USD BILLION)
FIGURE 44. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2027 (USD BILLION)
FIGURE 45. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2021 VS 2027 (%)
FIGURE 46. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2021 VS 2027 (USD BILLION)
FIGURE 47. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY AGE GROUP, 2027
FIGURE 48. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, 2018-2027 (USD BILLION)
FIGURE 49. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, 2018-2027 (USD BILLION)
FIGURE 50. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, 2018-2027 (USD BILLION)
FIGURE 51. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2021 VS 2027 (%)
FIGURE 52. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2021 VS 2027 (USD BILLION)
FIGURE 53. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION CHANNELS, 2027
FIGURE 54. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, 2018-2027 (USD BILLION)
FIGURE 55. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, 2018-2027 (USD BILLION)
FIGURE 56. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 58. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 59. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 60. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 66. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 67. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 68. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 70. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 71. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 72. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 74. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 75. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 76. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 77. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 78. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 79. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 80. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 81. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 82. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 83. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 84. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 85. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 86. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 87. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 88. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 89. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 90. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 91. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 92. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 93. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 94. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 95. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 96. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 97. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 98. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 99. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 100. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 101. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 102. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 103. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 104. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 105. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 106. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 107. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 108. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 109. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 110. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 111. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, 2018-2027 (USD BILLION)
TABLE 21. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 22. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 23. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, 2018-2027 (USD BILLION)
TABLE 24. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, BY REGION, 2018-2027 (USD BILLION)
TABLE 25. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, BY REGION, 2018-2027 (USD BILLION)
TABLE 26. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, 2018-2027 (USD BILLION)
TABLE 27. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 28. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 29. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, 2018-2027 (USD BILLION)
TABLE 30. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2018-2027 (USD BILLION)
TABLE 31. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2018-2027 (USD BILLION)
TABLE 32. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 33. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CANCER, 2018-2027 (USD BILLION)
TABLE 34. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 35. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 36. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2027 (USD BILLION)
TABLE 37. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2027 (USD BILLION)
TABLE 38. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2027 (USD BILLION)
TABLE 39. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, 2018-2027 (USD BILLION)
TABLE 40. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, BY REGION, 2018-2027 (USD BILLION)
TABLE 41. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, BY REGION, 2018-2027 (USD BILLION)
TABLE 42. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN, 2018-2027 (USD BILLION)
TABLE 43. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN, BY REGION, 2018-2027 (USD BILLION)
TABLE 44. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN, BY REGION, 2018-2027 (USD BILLION)
TABLE 45. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2027 (USD BILLION)
TABLE 46. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2027 (USD BILLION)
TABLE 47. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2027 (USD BILLION)
TABLE 48. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 49. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, 2018-2027 (USD BILLION)
TABLE 50. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 51. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 52. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, 2018-2027 (USD BILLION)
TABLE 53. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 54. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 55. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, 2018-2027 (USD BILLION)
TABLE 56. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 57. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 58. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2027 (USD BILLION)
TABLE 59. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 60. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 61. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 62. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, 2018-2027 (USD BILLION)
TABLE 63. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, BY REGION, 2018-2027 (USD BILLION)
TABLE 64. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, BY REGION, 2018-2027 (USD BILLION)
TABLE 65. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2027 (USD BILLION)
TABLE 66. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, BY REGION, 2018-2027 (USD BILLION)
TABLE 67. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, BY REGION, 2018-2027 (USD BILLION)
TABLE 68. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 69. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, 2018-2027 (USD BILLION)
TABLE 70. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 71. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 72. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, 2018-2027 (USD BILLION)
TABLE 73. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 74. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 75. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, 2018-2027 (USD BILLION)
TABLE 76. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2027 (USD BILLION)
TABLE 77. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2027 (USD BILLION)
TABLE 78. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 79. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, 2018-2027 (USD BILLION)
TABLE 80. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, BY REGION, 2018-2027 (USD BILLION)
TABLE 81. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, BY REGION, 2018-2027 (USD BILLION)
TABLE 82. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, 2018-2027 (USD BILLION)
TABLE 83. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, BY REGION, 2018-2027 (USD BILLION)
TABLE 84. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, BY REGION, 2018-2027 (USD BILLION)
TABLE 85. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 86. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 87. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 88. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 89. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 90. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 91. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 92. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 93. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 94. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 95. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 96. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 97. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 98. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 99. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 100. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 101. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 102. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 103. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 104. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 105. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 106. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 107. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 108. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 109. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 110. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 111. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 112. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 113. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 114. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 115. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 116. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 117. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 118. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 119. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 120. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 121. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 122. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 123. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 124. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 125. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 126. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 127. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 128. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 129. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 130. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 131. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 132. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 133. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 134. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 135. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 136. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 137. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 138. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 139. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 140. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 141. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 142. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 143. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 144. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 145. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 146. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 147. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 148. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 149. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 150. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 151. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 152. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 153. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 154. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 155. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 156. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 157. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 158. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 159. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 160. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 161. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 162. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 163. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 164. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 165. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 166. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 167. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 168. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 169. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 170. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 171. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 172. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 173. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 174. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 175. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 176. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 177. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 178. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 179. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 180. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 181. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 182. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 183. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 184. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 185. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 186. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 187. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 188. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 189. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 190. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 191. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 192. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 193. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 194. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 195. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 196. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 197. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 198. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 199. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 200. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 201. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 202. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 203. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 204. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 205. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 206. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 207. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 208. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 209. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 210. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 211. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 212. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 213. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 214. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 215. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 216. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 217. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 218. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 219. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 220. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 221. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 222. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 223. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 224. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 225. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 226. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 227. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 228. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 229. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 230. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 231. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 232. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 233. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 234. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 235. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 236. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 237. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 238. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 239. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 249. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 250. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 251. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 252. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 253. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 254. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 255. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 256. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 257. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 258. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 259. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 260. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 261. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 262. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 263. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 264. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 265. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 266. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 267. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 268. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 269. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 270. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 271. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 272. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 273. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 274. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 275. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 276. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 277. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 278. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 279. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 280. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 281. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 282. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 283. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 284. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 285. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 286. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 287. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 288. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 289. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 290. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 291. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 292. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 293. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 294. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 295. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 296. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 297. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 298. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 299. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 300. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 301. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 302. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 303. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 304. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2027 (USD BILLION)
TABLE 305. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 306. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2027 (USD BILLION)
TABLE 307. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2027 (USD BILLION)
TABLE 308. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2027 (USD BILLION)
TABLE 309. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2018-2027 (USD BILLION)
TABLE 310. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2027 (USD BILLION)
TABLE 311. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2027 (USD BILLION)
TABLE 312. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUT